Résumé
Abstract only
- Titre
- IMMUNO-MODULATION IN AMYOTROPHIC LATERAL SCLEROSIS - A PHASE II STUDY OF SAFETY AND ACTIVITY OF LOW DOSE INTERLEUKIN-2 (IMODALS study) (S3.006)
- Créateurs - sans rôle
- Gilbert Bensimon - Assistance Publique – Hôpitaux de ParisWilliam Camu - Centre Gui de Chauliac Montpellier FranceChristine Payan - BESPIM, Nîmes University Hospital, Nîmes, & Dept of Clinical Pharmacology, Pitié-Salpêtrière University Hospital Paris FranceTimothy Tree - King's College LondonJean-Luc Veyrune - CHU Saint Eloi Montpellier FranceAndrea Malaspina - Queen Mary University of LondonCecilia Garlanda - Humanitas Clinical Research Center Rozzano ItalyMassimo Locati - Humanitas Clinical Research Center Rozzano ItalySafaa Saker - GenethonRaul Juntas-Morales - Clinique du Motoneurone, Centre Hospitalo-Universitaire Gui de Chauliac Montpellier FranceNicolas Pageot - Clinique du Motoneurone, Centre Hospitalo-Universitaire Gui de Chauliac Montpellier FranceJohn De Vos - Cell Processing Facility, Department for Cell and Tissue Engineering, CHU Saint Eloi Montpellier FranceJanine Kirby - Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield Sheffield FranceAmmar Al-Chalabi - King’s College London London United KingdomPeter Leigh - University of Sussex
- Détails de publication
- Neurology, Vol.88(16_supplement)
- Identifiants
- 99141200809311
- Unité académique
- Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB; Institut des Neurosciences de Montpellier - INM
- Langue
- English
- Type de ressource
- Journal article